These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
568 related articles for article (PubMed ID: 21571835)
1. Differential hypoxic regulation of hypoxia-inducible factors 1alpha and 2alpha. Lin Q; Cong X; Yun Z Mol Cancer Res; 2011 Jun; 9(6):757-65. PubMed ID: 21571835 [TBL] [Abstract][Full Text] [Related]
2. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase. Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Björkholm M; Liu Z; Xu D Mol Cancer Res; 2007 Aug; 5(8):793-800. PubMed ID: 17699105 [TBL] [Abstract][Full Text] [Related]
3. Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses. Yoon H; Shin SH; Shin DH; Chun YS; Park JW Biochem Biophys Res Commun; 2014 Jan; 444(1):36-43. PubMed ID: 24423936 [TBL] [Abstract][Full Text] [Related]
4. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions. Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells. Bordji K; Grandval A; Cuhna-Alves L; Lechapt-Zalcman E; Bernaudin M FEBS J; 2014 Dec; 281(23):5220-36. PubMed ID: 25244496 [TBL] [Abstract][Full Text] [Related]
6. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation. Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013 [TBL] [Abstract][Full Text] [Related]
7. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha. Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007 [TBL] [Abstract][Full Text] [Related]
8. Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia. Aquino-Gálvez A; González-Ávila G; Delgado-Tello J; Castillejos-López M; Mendoza-Milla C; Zúñiga J; Checa M; Maldonado-Martínez HA; Trinidad-López A; Cisneros J; Torres-Espíndola LM; Hernández-Jiménez C; Sommer B; Cabello-Gutiérrez C; Gutiérrez-González LH Oncol Rep; 2016 Jan; 35(1):577-83. PubMed ID: 26548300 [TBL] [Abstract][Full Text] [Related]
9. The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Koh MY; Lemos R; Liu X; Powis G Cancer Res; 2011 Jun; 71(11):4015-27. PubMed ID: 21512133 [TBL] [Abstract][Full Text] [Related]
10. Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α. Ahmad A; Ahmad S; Malcolm KC; Miller SM; Hendry-Hofer T; Schaack JB; White CW Am J Respir Cell Mol Biol; 2013 Jul; 49(1):78-85. PubMed ID: 23492195 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. Mole DR; Blancher C; Copley RR; Pollard PJ; Gleadle JM; Ragoussis J; Ratcliffe PJ J Biol Chem; 2009 Jun; 284(25):16767-16775. PubMed ID: 19386601 [TBL] [Abstract][Full Text] [Related]
12. Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Aprelikova O; Wood M; Tackett S; Chandramouli GV; Barrett JC Cancer Res; 2006 Jun; 66(11):5641-7. PubMed ID: 16740701 [TBL] [Abstract][Full Text] [Related]
13. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Carroll VA; Ashcroft M Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202 [TBL] [Abstract][Full Text] [Related]
14. Regulation of the HIF-system in human macrophages--differential regulation of HIF-α subunits under sustained hypoxia. Poitz DM; Augstein A; Hesse K; Christoph M; Ibrahim K; Braun-Dullaeus RC; Strasser RH; Schmeißer A Mol Immunol; 2014 Feb; 57(2):226-35. PubMed ID: 24176785 [TBL] [Abstract][Full Text] [Related]
15. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Hu CJ; Wang LY; Chodosh LA; Keith B; Simon MC Mol Cell Biol; 2003 Dec; 23(24):9361-74. PubMed ID: 14645546 [TBL] [Abstract][Full Text] [Related]
16. Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Hu CJ; Iyer S; Sataur A; Covello KL; Chodosh LA; Simon MC Mol Cell Biol; 2006 May; 26(9):3514-26. PubMed ID: 16611993 [TBL] [Abstract][Full Text] [Related]
17. Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer. Kikuchi H; Pino MS; Zeng M; Shirasawa S; Chung DC Cancer Res; 2009 Nov; 69(21):8499-506. PubMed ID: 19843849 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha. Park SK; Dadak AM; Haase VH; Fontana L; Giaccia AJ; Johnson RS Mol Cell Biol; 2003 Jul; 23(14):4959-71. PubMed ID: 12832481 [TBL] [Abstract][Full Text] [Related]
19. HIF-1alpha and -2alpha genes in a hypoxia-sensitive teleost species Megalobrama amblycephala: cDNA cloning, expression and different responses to hypoxia. Shen RJ; Jiang XY; Pu JW; Zou SM Comp Biochem Physiol B Biochem Mol Biol; 2010 Nov; 157(3):273-80. PubMed ID: 20615476 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]